Skip to main content
Menu
Search
Search this site
Clinicians
Experts Speak
Case Study One
Case Study Two
Patient Management
Clinical Trials
Instructions for Use
Instructions for Use (USA)
Patient Manual
Resources
Product Literature
Program Development
Professional Resources
HeartWare Bibliography
HeartWare OnDemand
Reimbursement Resource Kits
Grant Requests
Patients & Caregivers
What is a VAD?
Patient Stories
Patient News
Resources
Patient Manual
Airline Letters
Current Treatment Options
Glossary of Terms
Site Finder
Products & Technology
Pump Design
Surgical Approach
Technology Pipeline
About Us
Company Profile
Our Mission
Leadership Team
Board of Directors
Meetings & Events
Contact Us
Careers
Our DNA
Current Openings
Investors
SEC Filings
News Releases
Annual Reports
Quarterly & Other Reports
Corporate Presentations
Resources
Image Library
Video Library
SEC Filings
Form 10-Q
HEARTWARE INTERNATIONAL, INC. filed this
Form 10-Q
on 11/07/2013
Document Outline
Entire Document (2278.7 KB)
Subdocument 1 - 10-Q - FORM 10-Q
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - References
Page 4 - PART I. FINANCIAL INFORMATION
Page 5 - HEARTWARE INTERNATIONAL, INC.
Page 6 - HEARTWARE INTERNATIONAL, INC.
Page 7 - HEARTWARE INTERNATIONAL, INC.
Page 8 - HEARTWARE INTERNATIONAL, INC.
Page 9 - HEARTWARE INTERNATIONAL, INC.
Page 10 - Note 3. Significant Accounting Policies
Page 11 - Inventories
Page 12 - Leases
Page 13 - New Accounting Standards
Page 14 - Assets That Are Measured at Fair Value on a Nonrecurring Basis
Page 15 - Note 5. Investments
Page 16 - Note 7. Property, Plant and Equipment, Net
Page 17 - Note 9. Other Accrued Liabilities
Page 18 - Debt with Conversion and Other Options
Page 19 - Note 11. Stockholders Equity
Page 20 - Equity Plans
Page 21 - Restricted Stock Units
Page 22 - Note 13. Net Loss Per Common Share
Page 23 - Litigation
Page 24 - ITEM 2: MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Page 25 - N/A
Page 26 - Critical Accounting Policies and Estimates
Page 27 - Cost of Revenue
Page 28 - Selling, General and Administrative
Page 29 - Foreign Exchange
Page 30 - Interest Expense
Page 31 - Cash Used in Operating Activities
Page 32 - Contractual Obligations
Page 33 - ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Page 34 - ITEM 4. CONTROLS AND PROCEDURES
Page 35 - PART II. OTHER INFORMATION
Page 36 - SIGNATURES
Page 37 - EXHIBIT INDEX
Subdocument 2 - EX-10.1 - EX-10.1
Page 1 - Exhibit 10.1
Page 2 - C.
Page 3 - A.
Page 4 - A. Sublessor s Work:
Page 5 - D.
Page 6 - A.
Page 7 - (ii)
Page 8 - C.
Page 9 - A.
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - A.
Page 14 - N/A
Page 15 - A.
Page 16 - B.
Page 17 - D.
Page 18 - A.
Page 19 - B.
Page 20 - B.
Page 21 - C.
Page 22 - D.
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - A.
Page 31 - (a)
Page 32 - N/A
Page 33 - 4:00 p.m.
Page 34 - IN WITNESS WHEREOF
Subdocument 3 - EX-31.1 - EX-31.1
Page 1 - Exhibit 31.1
Subdocument 4 - EX-31.2 - EX-31.2
Page 1 - Exhibit 31.2
Subdocument 5 - EX-32.1 - EX-32.1
Page 1 - Exhibit 32.1
Subdocument 6 - EX-32.2 - EX-32.2
Page 1 - Exhibit 32.2
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT
(
What's this?
)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
(
What's this?
)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
(
What's this?
)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
(
What's this?
)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
(
What's this?
)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
(
What's this?
)
XBRL Viewer
Print Page
Email Page
RSS Feeds
Investor Relations
Investor Relations Home
Corporate Profile
Investor Fact Sheet
Share Price Information
Stock Quote
Historical Price Lookup
Investment Calculator
ASX Announcements
ASX Delisting
SEC Filings
News Releases
Annual Reports
Quarterly & Other Reports
Corporate Presentations
Events Calendar
Upcoming Events
Past Events
Corporate Governance
Highlights
Management
Board of Directors
Committee Composition
Shareholder Services
Analyst Coverage
Investor FAQs
Email Alerts
Contact Investor Relations